I'm sticking my neck out on this stock at this point in time. I'm not going to be right all the time, but I'm at least 1-for-1 thus far this year on such calls. I doubled the money I'd placed on my Arena put option last month when I predicted correctly that it wouldn't receive CHMP ruling in January, much to the chagrin of all who had bid that stock price up. I feel we will see a strong move up with Curis in the next month or two based on the two catalysts previously mentioned. IMO its highly likely that CHMP rules in the next two months, and it has a good chance to be this month, as its already overdue. As a novel cancer treatment, I also expect it to be approved when this ruling does come. Having a powerful and no doubt influential partner in Roche certainly doesn't hurt its prospects in this regard, either.